Population Pharmacokinetics of Caspofungin and Dose Simulations in Heart Transplant Recipients

A nomogram incorporating functional and tubular damage biomarkers to predict the risk of acute kidney injury for septic patients

(2021) Jianchao Ma et al.   BMC Nephrology

Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China

(2021) Fangyi Li et al.   Journal of Global Antimicrobial Resistance

Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population‐based cohort study

(2020) Seyed M. Hosseini‐Moghaddam et al.   Transplant Infectious Disease

Caspofungin weight-based dosing supported by a population pharmacokinetic model in critically ill patients

(2020) Anne-Grete Märtson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Non-stationary pharmacokinetics of caspofungin in ICU patients

(2020) Agnieszka Borsuk-De Moor et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population pharmacokinetics of caspofungin among extracorporeal membrane oxygenation (ECMO) patients during the postoperative period of lung transplantation(LTx)

(2020) Qianlin Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of thyroid function on cystatin C in detecting acute kidney injury: a prospective, observational study

(2019) Danqing Zhang et al.   BMC Nephrology

Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

(2019) S. Kurland et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of blood glucose levels on the accuracy of urinary N-acety-β-D-glucosaminidase for acute kidney injury detection in critically ill adults: a multicenter, prospective, observational study

(2019) Lin Wang et al.   BMC Nephrology

Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration

(2018) Alejandro Pérez-Pitarch et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Renal Complications Following Lung Transplantation and Heart Transplantation

(2018) Chethan M. Puttarajappa et al.   CRITICAL CARE CLINICS

Invasive fungal infection after heart transplantation: A 7-year, single-center experience

(2017) Ignacio A. Echenique et al.   Transplant Infectious Disease

Low caspofungin exposure in patients in the Intensive Care Unit

(2016) Kim C.M. van der Elst et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration

(2016) Claire Roger et al.   CLINICAL PHARMACOKINETICS

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

What about confidence intervals? A word of caution when interpreting PTA simulations

(2016) Pieter Colin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes

(2015) Jessica C. Song et al.   CRITICAL REVIEWS IN MICROBIOLOGY

How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?

(2014) T.W. Felton et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antifungal prophylaxis following heart transplantation: systematic review

(2014) Luis G. Uribe et al.   MYCOSES

Impact of Targeted Antifungal Prophylaxis in Heart Transplant Recipients at High Risk for Early Invasive Fungal Infection

(2014) Frederic Tissot et al.   TRANSPLANTATION

Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis

(2013) Gudrun Würthwein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-Fourths

(2013) Ronald G. Hall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical implications of antibiotic pharmacokinetic principles in the critically ill

(2013) Andrew A. Udy et al.   INTENSIVE CARE MEDICINE

Targeted Antifungal Prophylaxis in Heart Transplant Recipients

(2013) Patricia Muñoz et al.   TRANSPLANTATION

Introduction to Drug Pharmacokinetics in the Critically III Patient

(2012) Brian S. Smith et al.   CHEST

Risk factors for post-transplant low output syndrome

(2012) T. Fujita et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients

(2011) Gudrun Würthwein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

(2010) D. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients

(2010) Marta Ulldemolins et al.   CLINICAL PHARMACOKINETICS

Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

(2010) M. Winkler et al.   Transplant Infectious Disease

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R

(2008) Emmanuelle Comets et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Caspofungin as First-Line Therapy for the Treatment of Invasive Aspergillosis After Thoracic Organ Transplantation

(2008) Jan Groetzner et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION